Clinical trial for the evaluation of the efficacy and safety of KACC91563 on atopic dermatitis in childre
Not Applicable
Completed
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0003822
- Lead Sponsor
- Aram
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1) The subjects and their parents(or legal representatives), who has agreed to participate in this study and voluntarily signed the Informed consent form
2) The subjects, who aged between 1 and 12 years
3) The subjects, who has intermittent or continuous atopic dermatitis more than 6 months
Exclusion Criteria
1) The subjects with severe skin and systemic diseases other than atopic dermatitis
2) The subjects, who has administered systemic antibiotics, corticosteroids, antihistamines and immunosuppressants for atopic dermatitis within 1 week before the human application test.
3) The subjects, who is deemed unfit for this human application test by the Investigator
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCORAD(SCORing of Atopic Dermatitis)
- Secondary Outcome Measures
Name Time Method IGA(Investigator's global assessment)